Assay method for organic calcium antagonist drugs and a kit for such an assay
Creators
Description
A method for measuring the level of organic calcium antagonist drug in a body fluid comprises preparing a mixture of a radioactive calcium antagonist drug, a body fluid containing a calcium antagonist drug and a calcium antagonist receptor material, measuring the radioactivity of the radioactive calcium antagonist drug bound to said calcium antagonist receptor material and deriving the concentration of the calcium antagonist drug in the body fluid from a standard curve indicating the concentration of calcium antagonist drug versus inhibition of binding of said radioactive calcium antagonist drug to said receptor sites caused by the calcium antagonist drug in said body fluid. A kit for measuring the level of an organic calcium drug comprises a receptacle containing a radioactive calcium antagonist drug, a calcium antagonist receptor material and a standard amount of a nonradioactive calcium antagonist drug
Availability note (English)
U.S. Commissioner of Patents, Washington, D.C. 20231, USA, $.50.Additional details
Publishing Information
- Imprint Pagination
- v p.
- IPC:
- Int. Cl. G01N 33/60; G01T 1/00.
- IPC
- Int. Cl. G01N 33/60; G01T 1/00.
- Patent number
- US patent document 4,520,112/A/
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 17035985
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Non-conventional Literature
- Descriptors DEI
- BODY FLUIDS; CALCIUM COMPOUNDS; CHEMICAL COMPOSITION; CHEMICAL PREPARATION; DRUGS; LEVELS; MEASURING METHODS; ORGANIC COMPOUNDS; QUANTITATIVE CHEMICAL ANALYSIS; RADIOACTIVATION
- Descriptors DEC
- ALKALINE EARTH METAL COMPOUNDS; BIOLOGICAL MATERIALS; CHEMICAL ANALYSIS; MATERIALS; SYNTHESIS
Optional Information
- Notes
- PAT-APPL-473622.